# Vonoprazan in Helicobacter Pylori Treatment an RCT

> **NCT04901663** · PHASE4 · COMPLETED · sponsor: **Dow University of Health Sciences** · enrollment: 179 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Omeprazole 20 MG Capsule; Amoxicillin 1000 MG; Clarithromycin 500 MG
- **DRUG:** Vonoprazan 20 MG; Amoxicillin 1000 MG

## Key facts

- **NCT ID:** NCT04901663
- **Lead sponsor:** Dow University of Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-21
- **Primary completion:** 2021-08-13
- **Final completion:** 2021-08-16
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2021-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901663, "Vonoprazan in Helicobacter Pylori Treatment an RCT". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT04901663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*